MERIDIAN
M&AConsumerRUMOURED

Mesoestetic hires Santander to analyze its sale

Photo via Pexels
Target
Mesoestetic

Mesoestetic, a company specializing in medical cosmetics and aesthetic medicine, has engaged Santander to explore options for its potential sale. This move suggests the company is considering strategic alternatives.

✦ Meridian Analysis
Mesoestetic, a Spanish family-owned company specializing in medical cosmetics and aesthetic medicine based in Viladecans, Barcelona, has hired Santander to manage investor interest regarding the potential acquisition of a stake in the business, according to Expansión. Founded in 1985 and led by the second family generation since 2021, the company sells across more than 100 countries. For deal professionals assessing this asset sale, the mechanics center on how a stake transaction will be structured to bring in external capital while the Font family retains an ongoing equity interest, with the incoming partner's funds intended to accelerate growth and internationalization. Puig acquired the remaining 50% stake in Isdin for €1.2 billion, while JB Capital acquired a 50% stake in Sesderma and valued the company at €200 million. Mesoestetic reported revenue of nearly €87 million last year, representing a 6% increase, alongside EBITDA exceeding €20 million. Specific details regarding the exact size of the stake being offered, the identity of prospective bidders, the final valuation figure, and the expected timetable for binding offers have not been disclosed.
Read the original at Pepe Bravo (Expansion) →2026-10-20Europe
The Meridian Weekly

The week's largest deals and the Iberian ones, every Monday. Free.

MORE DEALS ON MERIDIAN ->